Kardiologie

PD Dr.med., Dr.sc.nat. Stefan Blöchlinger

Leitender Arzt Kardiologie
Leiter interventionelle Kardiologie
Facharzt für Kardiologie
Facharzt für Allgemeine Innere Medizin
Facharzt für Intensivmedizin

Beruflicher Werdegang

Seit 01/2018
Leitender Arzt Kardiologie
Leiter invasive Kardiologie
Kantonsspital Winterthur

2016
Habilitation im Fach Intensivmedizin an der Universität Bern

seit 09/2015
Leitender Arzt Kardiologie, Leiter Akutkardiologie & Bettenstation, klinische Tätigkeit im Bereich der invasiven & nichtinvasiven Kardiologie & interdisziplinären Intensivstation, Prof. S. Windecker & Prof. J. Takala

10/2012 – 09/2015
Oberarzt I in den Bereichen invasive & nichtinvasive Kardiologie & interdisziplinäre Intensivmedizin, Universitätsspital Bern, Prof. B. Meier & Prof. J. Takala

01/2012 – 09/2012
Fellowship invasive Kardiologie, Universitätsspital Bern, Prof. B. Meier & Prof. S. Windecker

09/2011 – 12/2011
Oberarzt Stv., interdisziplinäre Intensivmedizin, Universitätsspital Bern, Prof. J. Takala

03/2011 – 08/2011
Assistenzarzt Anästhesie, Bürgerspital Solothurn, Dr. P. Schumacher

09/2009 – 02/2011
Assistenzarzt interdisziplinäre Intensivmedizin, Universitätsspital Bern, Prof. Jukka Takala

Seit 2009
Senior Scientist, Universitätskliniken für Kardiologie & Intensivmedizin, Universitätsspital Bern Senior Scientist, Universitätskliniken für Kardiologie & Intensivmedizin, Universitätsspital Bern

09/2008 – 08/2009
Oberarzt Kardiologie, Spital Interlaken, Dr. U. Ingold

2007 – 2008
Assistenzarzt Kardiologie, Universitätsspital Bern, Inselspital, Prof. B. Meier

2005 – 2007
Assistenzarzt Innere Medizin & Intensivmedizin, Bürgerspital Solothurn, Prof. R. Schoenenberger

2005
Postdoc Position, Brain Research Institute, Prof. M.E. Schwab, Universität & ETH Zürich

2005
Doktorat in Medizin (Dr. med.) und Neurobiologie (Dr. sc. nat.)

2000 – 2002
Forschungsaufenthalt Cambridge, MA, USA, Neural Plasticity Research Group, Prof. C. J. Woolf, Massachusetts General Hospital & Harvard Medical School

1999, 2004
Research Fellow, Brain Research Institute, Prof. M. E. Schwab, Universität & ETH Zürich
Medizinstudium und Biologiestudium Universität Zürich, schweizerisches MD-PhD-Programm
Schulen in Winterthur, Maturität Typ B Kantonsschule Rychenberg

Mitgliedschaften

  • Schweizerische MD-PhD Vereinigung (SMPA)
  • Schweizerische Gesellschaft für Kardiologie (SGK)
  • Europäische Gesellschaft für Kardiologie (ESC)
  • Acute Cardiovascular Care Association (ACCA) der ESC
  • European Association of Percutaneous Cardiovascular Interventions (EAPCI) der ESC
  • Europäische Gesellschaft für Intensivmedizin (ESICM)
  1. Blochlinger S, Weinmann O, Schwab ME, Thallmair M.
    Neuronal plasticity and formation of new synaptic contacts follow pyramidal lesions and neutralization of nogo-a: A light and electron microscopic study in the pontine nuclei of adult rats.
    J Comp Neurol. 2001;433:426-436
  2. Woolf CJ, Bloechlinger S.
    Neuroscience. It takes more than two to nogo.
    Science. 2002;297:1132-1134
  3. Bloechlinger S, Karchewski LA, Woolf CJ.
    Dynamic changes in glypican-1 expression in dorsal root ganglion neurons after peripheral and central axonal injury.
    Eur J Neurosci. 2004;19:1119-1132
  4. Karchewski LA, Bloechlinger S, Woolf CJ.
    Axonal injury-dependent induction of the peripheral benzodiazepine receptor in small-diameter adult rat primary sensory neurons.
    Eur J Neurosci. 2004;20:671-683
  5. Dodd DA, Niederoest B, Bloechlinger S, Dupuis L, Loeffler JP, Schwab ME.
    Nogo-a, -b, and -c are found on the cell surface and interact together in many different cell types.
    J Biol Chem. 2005;280:12494-12502
  6. Bloechlinger S, Ingold U.
    Cardiac thrombus as a primary manifestation of polycythemia vera.
    Cardiovascular Medicine. 2010;13:281-283.
  7. Reintam Blaser A, Bloechlinger S.
    Should we be worried about disturbed sympathovagal balance during laparoscopic cholecystectomy?
    Minerva Anestesiol. 2010;76:876-878
  8. Bloechlinger S, Grander W, Bryner J, Dunser MW.
    Left ventricular rotation: A neglected aspect of the cardiac cycle.
    Intensive Care Med. 2011;37:156-163
  9. Torgersen C, Bloechlinger S, Schmittinger CA.
    Haemodynamic management of septic shock.
    International Journal of Intensive Care. 2011:5
  10. Wiegand JA, Torgersen C, Bloechlinger S, Takala J, Dunser MW.
    Influenza a(h1n1) infection and severe cardiac dysfunction in adults: A case series.
    Wien Klin Wochenschr. 2011;123:120-123
  11. Bloechlinger S, Berger D, Bryner J, Wiegand J, Dunser MW, Takala J.
    Left ventricular torsion abnormalities in septic shock and corrective effect of volume loading: A pilot study.
    Can J Cardiol. 2013;29:1665-1671
  12. Torgersen C, Meichtry J, Schmittinger CA, Bloechlinger S, Jakob SM, Takala J, Dunser MW.
    Haemodynamic variables and functional outcome in hypothermic patients following out-of-hospital cardiac arrest.
    Resuscitation. 2013;84:798-804
  13. Berger D, Bloechlinger S, Takala J, Sinderby C, Brander L.
    Heart-lung interactions during neurally adjusted ventilatory assist.
    Crit Care. 2014;18:499
  14. Bloechlinger S, Nebiker M, Windecker S.
    Unusual cause of myocardial infarction and congestive heart failure in a patient with prosthetic valve endocarditis.
    Catheter Cardiovasc Interv. 2014;83:E69-72
  15. Bloechlinger S, Berger D, Bryner J, Roost E, Jakob S, Dunser MW, Takala J.
    Changes in left ventricular torsion early postoperatively after aortic valve replacement and at long-term follow-up.
    J Cardiothorac Vasc Anesth. 2015;29:860-867
  16. Koskinas KC, Raber L, Zanchin T, Wenaweser P, Stortecky S, Moschovitis A, Khattab AA, Pilgrim T, Blochlinger S, Moro C, Juni P, Meier B, Heg D, Windecker S.
    Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions.
    Circ Cardiovasc Interv. 2015;8
  17. O’Sullivan CJ, Stortecky S, Butikofer A, Heg D, Zanchin T, Huber C, Pilgrim T, Praz F, Buellesfeld L, Khattab AA, Blochlinger S, Carrel T, Meier B, Zbinden S, Wenaweser P, Windecker S.
    Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.
    Circ Cardiovasc Interv. 2015;8:e001895
  18. Piccolo R, Stefanini GG, Franzone A, Spitzer E, Blochlinger S, Heg D, Juni P, Windecker S.
    Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: A meta-analysis.
    Circ Cardiovasc Interv. 2015;8
  19. Pilgrim T, Piccolo R, Heg D, Roffi M, Tuller D, Vuilliomenet A, Muller O, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Khattab AA, Taniwaki M, Rigamonti F, Nietlispach F, Blochlinger S, Wenaweser P, Juni P, Windecker S.
    Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction.
    EuroIntervention. 2015;11
  20. Schefold JC, Lainscak M, Hodoscek LM, Blochlinger S, Doehner W, Von Haehling S.
    Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure.
    ESC Heart Failure. 2015;2:122–128
  21. Spitzer E, Heg D, Stefanini GG, Stortecky S, Rutjes AW, Raber L, Blochlinger S, Pilgrim T, Juni P, Windecker S.
    Aspiration thrombectomy for treatment of st-segment elevation myocardial infarction: A meta-analysis of 26 randomized trials in 11,943 patients.
    Rev Esp Cardiol (Engl Ed). 2015;68:746-752
  22. Taniwaki M, Stefanini GG, Raber L, Brugaletta S, Cequier A, Heg D, Iniguez A, Kelbaek H, Serra A, Ostoijic M, Hernandez-Antolin R, Baumbach A, Blochlinger S, Juni P, Mainar V, Sabate M, Windecker S.
    Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: Insights from a pooled analysis of the comfortable ami and examination trials. EuroIntervention. 2015;11:391-398
  23. Berger D, Bloechlinger S, von Haehling S, Doehner W, Takala J, Z’Graggen WJ, Schefold JC.
    Dysfunction of respiratory muscles in critically ill patients on the intensive care unit.
    J Cachexia Sarcopenia Muscle. 2016
  24. Berger DC, Moller PW, Weber A, Bloch AM, Bloechlinger S, Haenggi M, Sondergaard S, Jakob SM, Magder S, Takala J.
    Effect of peep, blood volume, and inspiratory hold maneuvers on venous return.
    Am J Physiol Heart Circ Physiol. 2016:ajpheart 00931 02015
  25. Franzone A, Heg D, Raber L, Valgimigli M, Piccolo R, Zanchin T, Yamaji K, Stortecky S, Blochlinger S, Hunziker L, Praz F, Juni P, Windecker S, Pilgrim T.
    External validity of the „all-comers“ design: Insights from the bioscience trial.
    Clin Res Cardiol. 2016
  26. Koskinas KC, Raber L, Zanchin T, Pilgrim T, Stortecky S, Hunziker L, Blochlinger S, Billinger M, Gartwyl F, Moro C, Moschovitis A, Juni P, Heg D, Windecker S.
    Duration of triple antithrombotic therapy and outcomes among patients undergoing percutaneous coronary intervention.
    JACC Cardiovasc Interv. 2016;9:1473-1483
  27. Pilgrim T, Vranckx P, Valgimigli M, Stefanini GG, Piccolo R, Rat J, Rothenbuhler M, Stortecky S, Raber L, Blochlinger S, Hunziker L, Silber S, Juni P, Serruys PW, Windecker S. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-st-segment elevation acute coronary syndrome, and st-segment elevation myocardial infarction. Am Heart J. 2016;175:56-65
  28. Wigger O, Windecker S, Bloechlinger S.
    Nonbacterial thrombotic endocarditis presenting as intracerebral hemorrhage.
    Wien Klin Wochenschr. 2016
  29. Zanchin T, Raber L, Koskinas KC, Piccolo R, Juni P, Pilgrim T, Stortecky S, Khattab AA, Wenaweser P, Bloechlinger S, Moschovitis A, Frenk A, Moro C, Meier B, Fiedler GM, Heg D, Windecker S.
    Preprocedural high-sensitivity cardiac troponin t and clinical outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.
    Circ Cardiovasc Interv. 2016;9
  30. Wigger O, Bloechlinger S, Berger D, Haner J, Zanchin T, Windecker S, Raber L, Schefold JC.
    Baseline serum bicarbonate levels independently predict short-term mortality in critically ill patients with ischaemic cardiogenic shock.
    Eur Heart J Acute Cardiovasc Care. 2016:2048872616683526
  31. Grubler MR, Wigger O, Berger D, Blochlinger S.
    Basic concepts of heart-lung interactions during mechanical ventilation.
    Swiss Med Wkly. 2017;147:w14491
  32. Vierecke J, Stortecky S, Blöchlinger S, Hunziker L, Seiler C.
    Mechanical complication of an infarct or of its treatment?
    Cardiovascular Medicine. 2016;19:335
  33. Hireche-Chikaoui H, Grubler MR, Bloch A, Windecker S, Bloechlinger S, Hunziker L.
    Nonejecting hearts on femoral veno-arterial extracorporeal membrane oxygenation: Aortic root blood stasis and thrombus formation-a case series and review of the literature.
    Critical care medicine. 2018
  • Curriculum vitae

    Beruflicher Werdegang

    Seit 01/2018
    Leitender Arzt Kardiologie
    Leiter invasive Kardiologie
    Kantonsspital Winterthur

    2016
    Habilitation im Fach Intensivmedizin an der Universität Bern

    seit 09/2015
    Leitender Arzt Kardiologie, Leiter Akutkardiologie & Bettenstation, klinische Tätigkeit im Bereich der invasiven & nichtinvasiven Kardiologie & interdisziplinären Intensivstation, Prof. S. Windecker & Prof. J. Takala

    10/2012 – 09/2015
    Oberarzt I in den Bereichen invasive & nichtinvasive Kardiologie & interdisziplinäre Intensivmedizin, Universitätsspital Bern, Prof. B. Meier & Prof. J. Takala

    01/2012 – 09/2012
    Fellowship invasive Kardiologie, Universitätsspital Bern, Prof. B. Meier & Prof. S. Windecker

    09/2011 – 12/2011
    Oberarzt Stv., interdisziplinäre Intensivmedizin, Universitätsspital Bern, Prof. J. Takala

    03/2011 – 08/2011
    Assistenzarzt Anästhesie, Bürgerspital Solothurn, Dr. P. Schumacher

    09/2009 – 02/2011
    Assistenzarzt interdisziplinäre Intensivmedizin, Universitätsspital Bern, Prof. Jukka Takala

    Seit 2009
    Senior Scientist, Universitätskliniken für Kardiologie & Intensivmedizin, Universitätsspital Bern Senior Scientist, Universitätskliniken für Kardiologie & Intensivmedizin, Universitätsspital Bern

    09/2008 – 08/2009
    Oberarzt Kardiologie, Spital Interlaken, Dr. U. Ingold

    2007 – 2008
    Assistenzarzt Kardiologie, Universitätsspital Bern, Inselspital, Prof. B. Meier

    2005 – 2007
    Assistenzarzt Innere Medizin & Intensivmedizin, Bürgerspital Solothurn, Prof. R. Schoenenberger

    2005
    Postdoc Position, Brain Research Institute, Prof. M.E. Schwab, Universität & ETH Zürich

    2005
    Doktorat in Medizin (Dr. med.) und Neurobiologie (Dr. sc. nat.)

    2000 – 2002
    Forschungsaufenthalt Cambridge, MA, USA, Neural Plasticity Research Group, Prof. C. J. Woolf, Massachusetts General Hospital & Harvard Medical School

    1999, 2004
    Research Fellow, Brain Research Institute, Prof. M. E. Schwab, Universität & ETH Zürich
    Medizinstudium und Biologiestudium Universität Zürich, schweizerisches MD-PhD-Programm
    Schulen in Winterthur, Maturität Typ B Kantonsschule Rychenberg

    Mitgliedschaften

    • Schweizerische MD-PhD Vereinigung (SMPA)
    • Schweizerische Gesellschaft für Kardiologie (SGK)
    • Europäische Gesellschaft für Kardiologie (ESC)
    • Acute Cardiovascular Care Association (ACCA) der ESC
    • European Association of Percutaneous Cardiovascular Interventions (EAPCI) der ESC
    • Europäische Gesellschaft für Intensivmedizin (ESICM)
  • Publikationen
    1. Blochlinger S, Weinmann O, Schwab ME, Thallmair M.
      Neuronal plasticity and formation of new synaptic contacts follow pyramidal lesions and neutralization of nogo-a: A light and electron microscopic study in the pontine nuclei of adult rats.
      J Comp Neurol. 2001;433:426-436
    2. Woolf CJ, Bloechlinger S.
      Neuroscience. It takes more than two to nogo.
      Science. 2002;297:1132-1134
    3. Bloechlinger S, Karchewski LA, Woolf CJ.
      Dynamic changes in glypican-1 expression in dorsal root ganglion neurons after peripheral and central axonal injury.
      Eur J Neurosci. 2004;19:1119-1132
    4. Karchewski LA, Bloechlinger S, Woolf CJ.
      Axonal injury-dependent induction of the peripheral benzodiazepine receptor in small-diameter adult rat primary sensory neurons.
      Eur J Neurosci. 2004;20:671-683
    5. Dodd DA, Niederoest B, Bloechlinger S, Dupuis L, Loeffler JP, Schwab ME.
      Nogo-a, -b, and -c are found on the cell surface and interact together in many different cell types.
      J Biol Chem. 2005;280:12494-12502
    6. Bloechlinger S, Ingold U.
      Cardiac thrombus as a primary manifestation of polycythemia vera.
      Cardiovascular Medicine. 2010;13:281-283.
    7. Reintam Blaser A, Bloechlinger S.
      Should we be worried about disturbed sympathovagal balance during laparoscopic cholecystectomy?
      Minerva Anestesiol. 2010;76:876-878
    8. Bloechlinger S, Grander W, Bryner J, Dunser MW.
      Left ventricular rotation: A neglected aspect of the cardiac cycle.
      Intensive Care Med. 2011;37:156-163
    9. Torgersen C, Bloechlinger S, Schmittinger CA.
      Haemodynamic management of septic shock.
      International Journal of Intensive Care. 2011:5
    10. Wiegand JA, Torgersen C, Bloechlinger S, Takala J, Dunser MW.
      Influenza a(h1n1) infection and severe cardiac dysfunction in adults: A case series.
      Wien Klin Wochenschr. 2011;123:120-123
    11. Bloechlinger S, Berger D, Bryner J, Wiegand J, Dunser MW, Takala J.
      Left ventricular torsion abnormalities in septic shock and corrective effect of volume loading: A pilot study.
      Can J Cardiol. 2013;29:1665-1671
    12. Torgersen C, Meichtry J, Schmittinger CA, Bloechlinger S, Jakob SM, Takala J, Dunser MW.
      Haemodynamic variables and functional outcome in hypothermic patients following out-of-hospital cardiac arrest.
      Resuscitation. 2013;84:798-804
    13. Berger D, Bloechlinger S, Takala J, Sinderby C, Brander L.
      Heart-lung interactions during neurally adjusted ventilatory assist.
      Crit Care. 2014;18:499
    14. Bloechlinger S, Nebiker M, Windecker S.
      Unusual cause of myocardial infarction and congestive heart failure in a patient with prosthetic valve endocarditis.
      Catheter Cardiovasc Interv. 2014;83:E69-72
    15. Bloechlinger S, Berger D, Bryner J, Roost E, Jakob S, Dunser MW, Takala J.
      Changes in left ventricular torsion early postoperatively after aortic valve replacement and at long-term follow-up.
      J Cardiothorac Vasc Anesth. 2015;29:860-867
    16. Koskinas KC, Raber L, Zanchin T, Wenaweser P, Stortecky S, Moschovitis A, Khattab AA, Pilgrim T, Blochlinger S, Moro C, Juni P, Meier B, Heg D, Windecker S.
      Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions.
      Circ Cardiovasc Interv. 2015;8
    17. O’Sullivan CJ, Stortecky S, Butikofer A, Heg D, Zanchin T, Huber C, Pilgrim T, Praz F, Buellesfeld L, Khattab AA, Blochlinger S, Carrel T, Meier B, Zbinden S, Wenaweser P, Windecker S.
      Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.
      Circ Cardiovasc Interv. 2015;8:e001895
    18. Piccolo R, Stefanini GG, Franzone A, Spitzer E, Blochlinger S, Heg D, Juni P, Windecker S.
      Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: A meta-analysis.
      Circ Cardiovasc Interv. 2015;8
    19. Pilgrim T, Piccolo R, Heg D, Roffi M, Tuller D, Vuilliomenet A, Muller O, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Khattab AA, Taniwaki M, Rigamonti F, Nietlispach F, Blochlinger S, Wenaweser P, Juni P, Windecker S.
      Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction.
      EuroIntervention. 2015;11
    20. Schefold JC, Lainscak M, Hodoscek LM, Blochlinger S, Doehner W, Von Haehling S.
      Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure.
      ESC Heart Failure. 2015;2:122–128
    21. Spitzer E, Heg D, Stefanini GG, Stortecky S, Rutjes AW, Raber L, Blochlinger S, Pilgrim T, Juni P, Windecker S.
      Aspiration thrombectomy for treatment of st-segment elevation myocardial infarction: A meta-analysis of 26 randomized trials in 11,943 patients.
      Rev Esp Cardiol (Engl Ed). 2015;68:746-752
    22. Taniwaki M, Stefanini GG, Raber L, Brugaletta S, Cequier A, Heg D, Iniguez A, Kelbaek H, Serra A, Ostoijic M, Hernandez-Antolin R, Baumbach A, Blochlinger S, Juni P, Mainar V, Sabate M, Windecker S.
      Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: Insights from a pooled analysis of the comfortable ami and examination trials. EuroIntervention. 2015;11:391-398
    23. Berger D, Bloechlinger S, von Haehling S, Doehner W, Takala J, Z’Graggen WJ, Schefold JC.
      Dysfunction of respiratory muscles in critically ill patients on the intensive care unit.
      J Cachexia Sarcopenia Muscle. 2016
    24. Berger DC, Moller PW, Weber A, Bloch AM, Bloechlinger S, Haenggi M, Sondergaard S, Jakob SM, Magder S, Takala J.
      Effect of peep, blood volume, and inspiratory hold maneuvers on venous return.
      Am J Physiol Heart Circ Physiol. 2016:ajpheart 00931 02015
    25. Franzone A, Heg D, Raber L, Valgimigli M, Piccolo R, Zanchin T, Yamaji K, Stortecky S, Blochlinger S, Hunziker L, Praz F, Juni P, Windecker S, Pilgrim T.
      External validity of the „all-comers“ design: Insights from the bioscience trial.
      Clin Res Cardiol. 2016
    26. Koskinas KC, Raber L, Zanchin T, Pilgrim T, Stortecky S, Hunziker L, Blochlinger S, Billinger M, Gartwyl F, Moro C, Moschovitis A, Juni P, Heg D, Windecker S.
      Duration of triple antithrombotic therapy and outcomes among patients undergoing percutaneous coronary intervention.
      JACC Cardiovasc Interv. 2016;9:1473-1483
    27. Pilgrim T, Vranckx P, Valgimigli M, Stefanini GG, Piccolo R, Rat J, Rothenbuhler M, Stortecky S, Raber L, Blochlinger S, Hunziker L, Silber S, Juni P, Serruys PW, Windecker S. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-st-segment elevation acute coronary syndrome, and st-segment elevation myocardial infarction. Am Heart J. 2016;175:56-65
    28. Wigger O, Windecker S, Bloechlinger S.
      Nonbacterial thrombotic endocarditis presenting as intracerebral hemorrhage.
      Wien Klin Wochenschr. 2016
    29. Zanchin T, Raber L, Koskinas KC, Piccolo R, Juni P, Pilgrim T, Stortecky S, Khattab AA, Wenaweser P, Bloechlinger S, Moschovitis A, Frenk A, Moro C, Meier B, Fiedler GM, Heg D, Windecker S.
      Preprocedural high-sensitivity cardiac troponin t and clinical outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.
      Circ Cardiovasc Interv. 2016;9
    30. Wigger O, Bloechlinger S, Berger D, Haner J, Zanchin T, Windecker S, Raber L, Schefold JC.
      Baseline serum bicarbonate levels independently predict short-term mortality in critically ill patients with ischaemic cardiogenic shock.
      Eur Heart J Acute Cardiovasc Care. 2016:2048872616683526
    31. Grubler MR, Wigger O, Berger D, Blochlinger S.
      Basic concepts of heart-lung interactions during mechanical ventilation.
      Swiss Med Wkly. 2017;147:w14491
    32. Vierecke J, Stortecky S, Blöchlinger S, Hunziker L, Seiler C.
      Mechanical complication of an infarct or of its treatment?
      Cardiovascular Medicine. 2016;19:335
    33. Hireche-Chikaoui H, Grubler MR, Bloch A, Windecker S, Bloechlinger S, Hunziker L.
      Nonejecting hearts on femoral veno-arterial extracorporeal membrane oxygenation: Aortic root blood stasis and thrombus formation-a case series and review of the literature.
      Critical care medicine. 2018